Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Head and Neck Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Breast Neoplasms 2Zollinger-Ellison Syndrome 1Uterine Cervical Dysplasia 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Neoplasms 1Obesity 1Mouth Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Lymphocytic, Chronic, B-Cell 1Inflammation 1Gastrinoma 1Colorectal Neoplasms 1Chemotherapy Effect 1Burkitt Lymphoma 1

Interventions

bismuth tripotassium dicitrate 1S 1 (combination) 1Oxaliplatin 1Omeprazole 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Chemotherapy Effect × Omeprazole × Clear all
NCT06510010 2026-01-26

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
198 enrolled

Chemotherapy Effect

Data powered by HemOnc (CC BY 4.0) Colophon âš¡